<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Intern Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Korean J. Intern. Med</journal-id>
      <journal-title-group>
        <journal-title>The Korean Journal of Internal Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1226-3303</issn>
      <issn pub-type="epub">2005-6648</issn>
      <publisher>
        <publisher-name>Korean Association of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">10992726</article-id>
      <article-id pub-id-type="pmc">4531753</article-id>
      <article-id pub-id-type="doi">10.3904/kjim.2000.15.2.131</article-id>
      <article-id pub-id-type="publisher-id">kjim-15-2-131-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Secondary Renal Amyloidosis in Adult Onset Still&#x2019;s Disease: Case report and Review of the Literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Oh</surname>
            <given-names>Young Bae</given-names>
          </name>
          <degrees>MD.</degrees>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="af1-kjim-15-2-131-6">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bae</surname>
            <given-names>Sang-Cheol</given-names>
          </name>
          <degrees>MD.</degrees>
          <degrees>Ph.D.</degrees>
          <degrees>MPH.</degrees>
          <xref ref-type="corresp" rid="c1-kjim-15-2-131-6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jung</surname>
            <given-names>Ja-Hun</given-names>
          </name>
          <degrees>MD.</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Tae-Hwan</given-names>
          </name>
          <degrees>MD.</degrees>
          <degrees>Ph.D.</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jun</surname>
            <given-names>Jae-Bum</given-names>
          </name>
          <degrees>MD.</degrees>
          <degrees>Ph.D.</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jung</surname>
            <given-names>Sung-Soo</given-names>
          </name>
          <degrees>MD.</degrees>
          <degrees>Ph.D.</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>In-Hong</given-names>
          </name>
          <degrees>MD.</degrees>
          <degrees>Ph.D.</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoo</surname>
            <given-names>Dae-Hyun</given-names>
          </name>
          <degrees>MD.</degrees>
          <degrees>Ph.D.</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Moon Hyang</given-names>
          </name>
          <degrees>MD.</degrees>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="af2-kjim-15-2-131-6">
            <sup>**</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Seong Yoon</given-names>
          </name>
          <degrees>MD.</degrees>
          <degrees>Ph.D.</degrees>
        </contrib>
      </contrib-group>
      <aff id="af1-kjim-15-2-131-6"><label>*</label>Department of Rheumatology, Tong-Inchon Ghil Hospital, Gachon Medical School, Inchon, 400-170, Korea</aff>
      <aff id="af2-kjim-15-2-131-6"><label>**</label>The Hospital for Rheumatic Diseases, Department of Internal Medicine, Department of Pathology, Hanyang University Medical Center, Seoul, 133-792, Korea</aff>
      <author-notes>
        <corresp id="c1-kjim-15-2-131-6">Address reprint requests to: Sang-Cheol Bae, M.D., Ph.D., MPH., The Hospital for Rheumatic Diseases, Department of Internal Medicine, Hanyang University Medical Center, Seoul 133-792, Korea</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2000</year>
      </pub-date>
      <volume>15</volume>
      <issue>2</issue>
      <fpage>131</fpage>
      <lpage>134</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2000 The Korean Association of Internal Medicine</copyright-statement>
        <copyright-year>2000</copyright-year>
        <license>
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We report a 25-year-old Korean woman with Adult onset Still&#x2019;s disease (AOSD) presented with renal amyloidosis, which had developed four years after disease onset. We successfully treated her with prednisolone, colchicine and cyclophosphamide. A review of the literature uncovered about 10 cases, most of which were treated by various regimens that resulted in poor outcomes. Renal amyloidosis should be suspected in patients with AOSD who have unexplained proteinuria. Although the mechanism of renal amyloid deposition is not well known, earlier histopathologic diagnosis and choice of regimen may affect prognosis.</p>
      </abstract>
      <kwd-group>
        <kwd>Adult onset Still&#x2019;s disease</kwd>
        <kwd>Amyloidosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Adult onset Still&#x2019;s disease (AOSD) is a chronic systemic inflammatory disorder in which high spiking fever, typical skin rash, and polyarthritis occur. The main biological features are neutrophilic leukocytosis, hyperferritinemia, and negative rheumatoid factor (RF) or antinuclear antibodies (ANA). Others may include splenomegaly, pleuritis, pericarditis, and hepatic abnormalities<sup><xref rid="b1-kjim-15-2-131-6" ref-type="bibr">1</xref>)</sup>. Even though functional prognosis essentially depends on articular involvement, life-threatening prognosis depends on serious complications, such as hepatic failure, disseminated intravascular coagulopathy, hemophagocytosis, infections, amyloidosis, and cardiomyopathy<sup><xref rid="b2-kjim-15-2-131-6" ref-type="bibr">2</xref>&#x2013;<xref rid="b5-kjim-15-2-131-6" ref-type="bibr">5</xref>)</sup>. In this article, we describe a patient with AOSD who had secondary renal amyloidosis. We suggest a successful combined therapy of prednisolone (PD), colchicine (COL), and cyclophosphamide (CTX) and review the literature.</p>
    </sec>
    <sec>
      <title>CASE</title>
      <p>A 25-year-old Korean woman was diagnosed with AOSD four years ago after experiencing a high spiking fever, maculopapular rash, and polyarthritis in her hands, elbows and knees. In laboratory findings, the leukocyte count was 19,900/ <italic>&#x3BC;</italic>L, the serum ferritin level was 719.3 ng/mL (10&#x2013;240), and RF and ANA were negative. During a follow-up, typical skin rash had disappeared after administration of PD, sulfasalazine or hydroxychloroquine and methotraxate (MTX), but either high fever or polyarthitis was wax and wane, and occasionally, intra-articular injections of corticosteroid were administered. In July 1998, she was admitted to our hospital because of slowly increasing proteinuria over a 7 month period without pitting edema or hypertension. She was single and had no family history of any rheumatic disease or drug history, such as gold or D-penicilliamine.</p>
      <p>The results of laboratory data showed that the white-cell count (WBC) was 12,800 / <italic>&#x3BC;</italic>L, hemoglobin (Hb) was 10.6 g/dL, platelet was 610,000 / <italic>&#x3BC;</italic>L, ESR was 61 mm/hr, and C-reactive protein (CRP) was 9.50 mg/dL (&lt;0.8). The serum protein and albumin had decreased to 4.5 g/dL (6.4&#x2013;8.5) and 2.1 g/dL (3.2&#x2013;5.5), respectively. Serum ferritin was within the normal range. Serum autoantibodies and rheumatoid factor were persistently negative. There was no evidence of infection or malignancy. Several urine examinations showed proteinuria without any abnormality in urinary sediments. Twenty-four hour urine protein excretion was 6.9 g/day, and urine creatine clearance was 93.3 mL/min. In radiographic findings, chest PA was normal and bony erosions were detected in both wrist joints. In the sonography, the sizes of both kidneys were 11.5cm on the right and 11cm on the left side with increased renal parenchymal echogenicity.</p>
      <p>Renal biopsy showed amorphous deposits in the mesangial areas, some glomerular capillary walls and in the vascular poles (<xref ref-type="fig" rid="f1-kjim-15-2-131-6">Figure 1</xref>). The amyloid deposit stained with Congored displayed apple-green birefringence under the polarizing light. Immunofluorescence study for IgG, IgM, IgA, C3, C1, C4, fibrinogen, albumin, and light chains showed segmental positive staining for IgM and C3 in the mesangium and trace (&#xB1;) positive staining for light chain. Electron microscopic examination confirmed amyloid deposits in the mesangial areas, which were characterized by non-branching fibrils arranged in a random array (<xref ref-type="fig" rid="f2-kjim-15-2-131-6">Figure 2A</xref>, <xref ref-type="fig" rid="f2-kjim-15-2-131-6">2B</xref>). Serum protein electrophoresis showed a decrease in both total protein and total albumin without a monoclonal spike. Urine protein electrophoresis showed an elevated total protein level and an elevated total albumin level. Therefore, the final diagnosis was made of secondary renal amyloidosis due to AOSD.</p>
      <p>After one intravenous dosage of 500 mg methylprednisolone pulse therapy was administered. We maintained a high oral daily dose of PD (45 mg/day, 1 mg/kg), CTX (100 mg/day), and COL (1.2 mg/day). Two months later, the PD was tapered as proteinuria decreased. After a follow-up 15 months later, laboratory tests showed that the WBC was 6,000 /uL, Hb 13.2 g/dL, platelet 297,000 / <italic>&#x3BC;</italic>L, ESR 11 mm/hr, CRP 0.11 mg/dL, and the serum protein and albumin had increased to 6.2 g/dL and 4.2 g/dL, respectively. The serum ferritin was 24.3 ng/mL. The urine protein clearance was decreased from 6.9 g/day to 92 mg/day. Currently, she is taking PD 7.5 mg, CTX 50 mg, and COL 1.2 gm orally.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>AOSD is a disorder of unknown etiology and pathogenesis. The association of amyloid deposits and AOSD is rather unusual and should be considered a serious complication. The development of amyloidosis often occurs in patients with longstanding persistent inflammatory diseases<sup><xref rid="b5-kjim-15-2-131-6" ref-type="bibr">5</xref>,<xref rid="b6-kjim-15-2-131-6" ref-type="bibr">6</xref>)</sup>. According to previous histopathologic reports on AOSD, complicated renal amyloidosis usually develops after 18 months to 30 years. The incidence of renal amyloidosis in AOSD reveals 4.7% to 14.3%<sup><xref rid="b3-kjim-15-2-131-6" ref-type="bibr">3</xref>,<xref rid="b4-kjim-15-2-131-6" ref-type="bibr">4</xref>,<xref rid="b7-kjim-15-2-131-6" ref-type="bibr">7</xref>&#x2013;<xref rid="b12-kjim-15-2-131-6" ref-type="bibr">12</xref>)</sup>. We have experienced 45 patients with AOSD in our hospital and so far, found one case (2.2%) associated with renal amyloidosis<sup><xref rid="b13-kjim-15-2-131-6" ref-type="bibr">13</xref>)</sup>, which had developed four years after the onset of AOSD.</p>
      <p>When this complication occurs, amyloid material is preferentially deposited in the glomeruli, and proteinuria and nephrotic syndrome are the most common initial manifestations. There was no study regarding renal pathology in patients with AOSD. Helin et al.<sup><xref rid="b6-kjim-15-2-131-6" ref-type="bibr">6</xref>)</sup> demonstrated in a retrospective study of nephropathy in rheumatoid arthritis (RA) that the most common histopathologic finding was mesangial glomerulonephritis (GN), followed by amyloidosis. Amyloidosis was the most common finding in nephrotic syndrome. In a patient with isolated proteinuria, amyloidosis, membranous GN, and mesangial GN were almost equally common. Membranous GN was closely related to gold or D-penicillamine therapies, whereas mesangial GN probably was related to RA itself. Biopsy is thus a valuable tool in differential diagnosis, assessment of prognosis, and decision-making with regard to treatment.</p>
      <p>Although either NSAID or an oral steroid is usually effective in AOSD, some patients with complications of the renal amyloidosis may require sustained therapy with corticosteroid and a cytotoxic agent<sup><xref rid="b3-kjim-15-2-131-6" ref-type="bibr">3</xref>,<xref rid="b5-kjim-15-2-131-6" ref-type="bibr">5</xref>)</sup>. The COL was also effective in a patient with severe ankylosing spondylitis and nephrotic syndrome due to amyloidosis<sup><xref rid="b14-kjim-15-2-131-6" ref-type="bibr">14</xref>)</sup>. In review of 10 cases with AOSD complicated by renal amyloidosis, combined drug therapy with PD, COL, CTX, azathioprine, and MTX were used<sup><xref rid="b3-kjim-15-2-131-6" ref-type="bibr">3</xref>,<xref rid="b4-kjim-15-2-131-6" ref-type="bibr">4</xref>,<xref rid="b7-kjim-15-2-131-6" ref-type="bibr">7</xref>&#x2013;<xref rid="b12-kjim-15-2-131-6" ref-type="bibr">12</xref>)</sup>. In two of those cases, they were treated with steroids and dialysis due to renal failure<sup><xref rid="b4-kjim-15-2-131-6" ref-type="bibr">4</xref>,<xref rid="b11-kjim-15-2-131-6" ref-type="bibr">11</xref>)</sup>. In our experience, it has persistently decreased proteinuria as well as recovered polyarthritis or fever, without any severe complications, during the combined therapy of PD, COL, and CTX (<xref ref-type="table" rid="t1-kjim-15-2-131-6">Table 1</xref>).</p>
      <p>In conclusion, renal amyloidosis must be suspected in patients with AOSD who have unexplained proteinuria. Although the mechanism of renal amyloid deposition is unknown, early diagnosis and treatment with PD, COL, CTX may produce excellent results.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1-kjim-15-2-131-6">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamaguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ohta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tsunematsu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kasukawa</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mizushima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kashiwagi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kashiwazki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tanimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ota</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Akizuki</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Preliminary criteria for classification of adult Still&#x2019;s disease</article-title>
          <source>J Rheumatol</source>
          <volume>19</volume>
          <fpage>424</fpage>
          <lpage>430</lpage>
          <year>1992</year>
          <pub-id pub-id-type="pmid">1578458</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-kjim-15-2-131-6">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pouchot</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Samplis</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Beaudet</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Carette</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Decary</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Salussinsky-Sternbach</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>RO</given-names>
            </name>
            <name>
              <surname>Gutkowski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Harth</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Myhal</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Senecal</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Yeadon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Esdaile</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Adult Still&#x2019;s disease: manifestation, disease course and outcome in 62 patients</article-title>
          <source>Medicine</source>
          <volume>70</volume>
          <fpage>118</fpage>
          <lpage>136</lpage>
          <year>1991</year>
          <pub-id pub-id-type="pmid">2005777</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-kjim-15-2-131-6">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fautrel</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Borget</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rozenberg</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Loet</surname>
              <given-names>XL</given-names>
            </name>
            <name>
              <surname>Masson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Koeger</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Kahn</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Bougeois</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Corticosteroid sparing effect of lowdose methotrexate treatment in adult Still&#x2019;s disease</article-title>
          <source>J Rheumatol</source>
          <volume>26</volume>
          <fpage>373</fpage>
          <lpage>378</lpage>
          <year>1999</year>
          <pub-id pub-id-type="pmid">9972972</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-kjim-15-2-131-6">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bambery</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Malhotra</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Kaur</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Bhusnurmath</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Deodhar</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Adult onset Still&#x2019;s disease: clinical experience with 18 patients over 15 years in northern India</article-title>
          <source>Ann Rheum Dis</source>
          <volume>51</volume>
          <fpage>529</fpage>
          <lpage>532</lpage>
          <year>1992</year>
          <pub-id pub-id-type="pmid">1586255</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-kjim-15-2-131-6">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gertz</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kyle</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Amyloidosis: Prognosis and Treatment</article-title>
          <source>Semin Arthritis Rheum</source>
          <volume>24</volume>
          <fpage>124</fpage>
          <lpage>138</lpage>
          <year>1994</year>
          <pub-id pub-id-type="pmid">7839154</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-kjim-15-2-131-6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Helen</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Korpela</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Mustonen</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Pasternack</surname>
              <given-names>AI</given-names>
            </name>
          </person-group>
          <article-title>Renal biopsy findings and clinicopathologic correlations in Rheumatoid arthritis</article-title>
          <source>Arthritis Rheum</source>
          <volume>38</volume>
          <fpage>242</fpage>
          <lpage>247</lpage>
          <year>1995</year>
          <pub-id pub-id-type="pmid">7848315</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-kjim-15-2-131-6">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rivera</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gil</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Gil</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Batle-Gualda</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Triqueros</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Olivores</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Vascular renal AA amyloidosis in adult Still&#x2019;s disease</article-title>
          <source>Nephrol Dial Transplant</source>
          <volume>12</volume>
          <fpage>1714</fpage>
          <lpage>1716</lpage>
          <year>1997</year>
          <pub-id pub-id-type="pmid">9269657</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-kjim-15-2-131-6">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hashimoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shingu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ezaki</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Yoshikawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nobunaga</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Clinical studies on 14 cases of aduit-onset Still&#x2019;s disease</article-title>
          <source>Nihon Rinsho Meneki Gakkai Kaishi</source>
          <volume>18</volume>
          <fpage>45</fpage>
          <lpage>52</lpage>
          <year>1995</year>
          <pub-id pub-id-type="pmid">7553038</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-kjim-15-2-131-6">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ishii</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Muryoi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Murai</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hatakeyama</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Oosaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yusa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kawanami</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshinaga</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Systemic amyloidosis in a patients with adult onset Still&#x2019;s disease</article-title>
          <source>Intern Med</source>
          <volume>32</volume>
          <fpage>50</fpage>
          <lpage>52</lpage>
          <year>1993</year>
          <pub-id pub-id-type="pmid">8495045</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-kjim-15-2-131-6">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wendling</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Humbert</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Billerey</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fest</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dupond</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Adult onset Still&#x2019;s disease and related renal amyloidosis</article-title>
          <source>Ann Rheum Dis</source>
          <volume>50</volume>
          <fpage>257</fpage>
          <lpage>239</lpage>
          <year>1991</year>
          <pub-id pub-id-type="pmid">2029209</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-kjim-15-2-131-6">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vigneron</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Labrousse</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Leroux-Robert</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rene</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kahn</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Amyloidosis in adult Still&#x2019;s disease. Apropos of 2 case</article-title>
          <source>Ann Med Interne(Paris)</source>
          <volume>137</volume>
          <fpage>406</fpage>
          <lpage>408</lpage>
          <year>1986</year>
          <pub-id pub-id-type="pmid">3813274</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-kjim-15-2-131-6">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrinton</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Moran</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>De</given-names>
            </name>
          </person-group>
          <article-title>Amyloidosis in adult onset Still&#x2019;s disease</article-title>
          <source>J Rheumatol</source>
          <volume>8</volume>
          <fpage>833</fpage>
          <lpage>836</lpage>
          <year>1981</year>
          <pub-id pub-id-type="pmid">7310778</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-kjim-15-2-131-6">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cho</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Yun</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Shim</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Koh</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Jun</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>IH</given-names>
            </name>
            <name>
              <surname>Bae</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SY</given-names>
            </name>
          </person-group>
          <article-title>Adult onset Still&#x2019;s disease: Clinical features and prognostic factors in Korea</article-title>
          <source>J Kor Rheum Ass</source>
          <volume>5</volume>
          <fpage>64</fpage>
          <lpage>75</lpage>
          <year>1998</year>
        </element-citation>
      </ref>
      <ref id="b14-kjim-15-2-131-6">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Escakalante</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ehresmann</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Quismorio</surname>
              <given-names>FP</given-names>
            </name>
          </person-group>
          <article-title>Regression of reactive systemic amyloidosis due to ankylosing spondylitis following the administration of colchicine</article-title>
          <source>Athritis Rheum</source>
          <volume>34</volume>
          <fpage>920</fpage>
          <lpage>922</lpage>
          <year>1991</year>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-kjim-15-2-131-6" orientation="portrait" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>Amorphous deposits are located to the mesangial areas and in the vascular pole. (Masson&#x2019;s trichrome, X400).</p>
      </caption>
      <graphic xlink:href="kjim-15-2-131-6f1"/>
    </fig>
    <fig id="f2-kjim-15-2-131-6" orientation="portrait" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>Electron microscopy showed expanded mesangial matrix by amyloid deposits (A), which are characterized by non-branching fibrils arranged in random array (B). (A: X4,000, B: X35,000).</p>
      </caption>
      <graphic xlink:href="kjim-15-2-131-6f2"/>
    </fig>
    <table-wrap id="t1-kjim-15-2-131-6" orientation="portrait" position="float">
      <label>Table 1.</label>
      <caption>
        <p>Comparision of renal amyloidosis diagnosed by renal biopsy in patients with adult onset Still&#x2019;s disease: published cases.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" valign="middle" rowspan="1" colspan="1">Author (ref)</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">Age of disease onset, sex</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">Number of years before renal amyloidosis onset</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">Drug therapy for renal amyloidosis</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">Follow up duration after renal amyloidosis (months)</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">Outcome and complications</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Fautrel<xref rid="b3-kjim-15-2-131-6" ref-type="bibr">3</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">32 M</td>
            <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
            <td align="left" valign="top" rowspan="1" colspan="1">PD, MTX</td>
            <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Death, Bone marrow aplasia</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">River<xref rid="b7-kjim-15-2-131-6" ref-type="bibr">7</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">26 M</td>
            <td align="center" valign="top" rowspan="1" colspan="1">16</td>
            <td align="left" valign="top" rowspan="1" colspan="1">PD, AZA</td>
            <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Partial response</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Hashimoto<xref rid="b8-kjim-15-2-131-6" ref-type="bibr">8</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">25 F</td>
            <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
            <td align="left" valign="top" rowspan="1" colspan="1">PD</td>
            <td align="center" valign="top" rowspan="1" colspan="1">24</td>
            <td align="left" valign="top" rowspan="1" colspan="1">ND</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
            <td align="left" valign="top" rowspan="1" colspan="1">26 M</td>
            <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
            <td align="left" valign="top" rowspan="1" colspan="1">PD</td>
            <td align="center" valign="top" rowspan="1" colspan="1">24</td>
            <td align="left" valign="top" rowspan="1" colspan="1">ND</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Ishii<xref rid="b9-kjim-15-2-131-6" ref-type="bibr">9</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">32 F</td>
            <td align="center" valign="top" rowspan="1" colspan="1">7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">PD, CTX</td>
            <td align="center" valign="top" rowspan="1" colspan="1">16</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Death, Heart failure</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Bambery<xref rid="b4-kjim-15-2-131-6" ref-type="bibr">4</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">36 F</td>
            <td align="center" valign="top" rowspan="1" colspan="1">8</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Steroid, dialysis</td>
            <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Death, Renal failure</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Wendling<xref rid="b10-kjim-15-2-131-6" ref-type="bibr">10</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">57 F</td>
            <td align="center" valign="top" rowspan="1" colspan="1">4</td>
            <td align="left" valign="top" rowspan="1" colspan="1">ND</td>
            <td align="center" valign="top" rowspan="1" colspan="1">6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Gastrointestinal amyloidosis</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Vigneron<xref rid="b11-kjim-15-2-131-6" ref-type="bibr">11</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">23 F</td>
            <td align="center" valign="top" rowspan="1" colspan="1">1.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">PD, hemodialysis</td>
            <td align="center" valign="top" rowspan="1" colspan="1">6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Death, Gastrointestinal amyloidosis &amp; Renal failure</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1"/>
            <td align="left" valign="top" rowspan="1" colspan="1">27 F</td>
            <td align="center" valign="top" rowspan="1" colspan="1">4</td>
            <td align="left" valign="top" rowspan="1" colspan="1">PD, hemodialysis</td>
            <td align="center" valign="top" rowspan="1" colspan="1">7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Death, Renal failure</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Harrington<xref rid="b12-kjim-15-2-131-6" ref-type="bibr">12</xref></td>
            <td align="left" valign="top" rowspan="1" colspan="1">26 F</td>
            <td align="center" valign="top" rowspan="1" colspan="1">30</td>
            <td align="left" valign="top" rowspan="1" colspan="1">PD, COL</td>
            <td align="center" valign="top" rowspan="1" colspan="1">5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Persistent proteinuria</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn1-kjim-15-2-131-6">
          <p>Note; ND: non-described, PD: Prednisolone, MIX: methotrexate, AZA: Azathioprine, CTX: Cyclophosphamide, COL: colchicine.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
